News from atheronova inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 03, 2015, 08:45 ET

AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection

AtheroNova Inc. (OTCQB: AHRO) today announced that the Company and its subsidiary, AtheroNova Operations, Inc., filed voluntary petitions under...

Feb 19, 2015, 16:48 ET

AtheroNova Receives Additional Notices of Debt Acceleration

 AtheroNova Inc. (OTCQB: AHRO) today announced that after its filing of a Current Report on Form 8-K disclosing that on February 12, 2015 it...

Feb 13, 2015, 15:23 ET

AtheroNova Receives Notice of Debt Acceleration

 AtheroNova Inc. (OTCQB: AHRO) today announced that it filed a Current Report on Form 8-K disclosing that on February 12, 2015 it received a...

Feb 13, 2015, 08:10 ET

AtheroNova Receives Notice of Issuance of Its 3rd US Patent

 AtheroNova Inc. (OTCQB: AHRO) today announced that it has received a Notice of Issuance of Patent No. 8952067 titled "Subcutaneous Fat...

Oct 31, 2014, 16:13 ET

AtheroNova Announces Closing of Public Offering of Common Stock and Warrants

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 28, 2014, 17:58 ET

AtheroNova Prices Public Offering of Common Stock and Warrants

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jul 30, 2014, 07:00 ET

AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Dec 05, 2013, 07:00 ET

AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Oct 15, 2013, 07:00 ET

Atherosclerosis Researcher Dr. Erik Stroes Joins AtheroNova's Clinical Advisory Board

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Sep 19, 2013, 07:00 ET

AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 27, 2013, 08:00 ET

AtheroNova Announces Publication of Positive Pre-Clinical Results with AHRO-001 in the FASEB Journal

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jun 25, 2013, 07:00 ET

AtheroNova Initiates Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

May 30, 2013, 08:01 ET

AtheroNova Announces Shipment of Phase 1 Drug Product

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

May 09, 2013, 07:00 ET

AtheroNova Announces Approval for Phase 1 by the Russian Ministry of Healthcare with Commencement of Human Trials Imminent

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 15, 2013, 13:37 ET

Noted Atherosclerosis Researcher Joins AtheroNova Team

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Apr 11, 2013, 07:00 ET

AtheroNova Adds New Medical Advisor

 AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Mar 14, 2013, 18:18 ET

AtheroNova Announces Shareholder Realignment

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Jan 17, 2013, 07:00 ET

AtheroNova to Present at Noble Financial Capital Markets' Ninth Annual Equity Conference

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...

Jan 08, 2013, 08:00 ET

AtheroNova Names New Clinical Affairs Officer

 AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque...

Dec 18, 2012, 08:00 ET

AtheroNova Names New Chief Medical Officer

AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and...